LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

Home・Aandelen Lijst・Evolent Health Inc

Evolent Health Inc

Gesloten

SectorGezondheidszorg

2.71 -2.52

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

2.62

Max

2.7800000000000002

Belangrijke statistieken
By Trading Economics
Inkomsten	30M -21M
Verkoop	35M 480M
Winstmarge	-4.351
Werknemers	4,500
EBITDA	512K 15M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+186.74% upside

Dividenden
By Dow Jones
Volgende Winsten	24 feb 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-463M 317M
Vorige openingsprijs	5.23
Vorige sluitingsprijs	2.71

Technische score

By Trading Central

Vertrouwen

Very Strong Bullish Evidence

10.33 / 10.95 Steun & Weerstand

Evolent Health Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

17 feb 2026, 23:44 UTC

Populaire aandelen

Stocks to Watch: La-Z-Boy, Palo Alto Networks, Caesars

17 feb 2026, 23:20 UTC

Winsten

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps -- Update

17 feb 2026, 22:57 UTC

Winsten

Santos Fiscal Year Net Profit Falls 33%, Nears Start of Alaska Project

17 feb 2026, 21:59 UTC

Winsten

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps

17 feb 2026, 23:54 UTC

Marktinformatie

Nikkei May Rise as Fears About AI Disruption Ease -- Market Talk

17 feb 2026, 23:54 UTC

Marktinformatie

Global Equities Roundup: Market Talk

17 feb 2026, 23:54 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

17 feb 2026, 23:45 UTC

Marktinformatie

Suncorp's Outperformance of IAG Could Be Hard to Sustain -- Market Talk

17 feb 2026, 23:19 UTC

Winsten

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 feb 2026, 23:15 UTC

Winsten

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 feb 2026, 22:58 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Netflix Would Operate Warner's Studios, HBO Largely the Same -- Market Talk

17 feb 2026, 22:58 UTC

Acquisities, Fusies, Overnames

BlueScope Steel: Board Committed to Optimizing Value For Shareholders

17 feb 2026, 22:57 UTC

Acquisities, Fusies, Overnames

BlueScope Steel to Consider Revised SGH, Steel Dynamics Takeover Bid

17 feb 2026, 22:50 UTC

Acquisities, Fusies, Overnames

Agnico-Eagle Mines Acquired 662,780 Common Shrs of Maple Gold Mines at C$2.45 Per Common Shr >AEM.T

17 feb 2026, 22:44 UTC

Winsten

Palo Alto Reports Strong Earnings. Its Stock Is Down. -- Barrons.com

17 feb 2026, 22:42 UTC

Winsten

Santos FY Net Profit Falls 33%, Nears Start of Alaska Project

17 feb 2026, 22:36 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Netflix Sarandos: Paramount Causing Confusion Around Warner Deal -- Market Talk

17 feb 2026, 22:36 UTC

Winsten

Santos Final Dividend 10.3 U.S. Cents/Security

17 feb 2026, 22:36 UTC

Winsten

Santos FY Underlying Profit US$898 Million, Down 25%

17 feb 2026, 22:35 UTC

Winsten

Santos FY Revenue US$4.94 Billion, Down 8%

17 feb 2026, 22:35 UTC

Winsten

Correct: Santos FY Net Profit US$818 Million, Down 33%

17 feb 2026, 22:35 UTC

Acquisities, Fusies, Overnames

Berkshire Buys New York Times Stock; Sells Apple, Bank of America, Amazon In 4Q -- Barrons.com

17 feb 2026, 22:34 UTC

Winsten

Santos FY Net Profit US$818 Billion, Down 33%

17 feb 2026, 22:02 UTC

Acquisities, Fusies, Overnames

Berkshire Pares Stakes in Apple and BofA, Adds New York Times Position -- Update

17 feb 2026, 21:50 UTC

Acquisities, Fusies, Overnames

Steel Dynamics: SGH Would Buy BlueScope, On-sell North American Operations to SDI, As Earlier Proposed

17 feb 2026, 21:50 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Tech, Media & Telecom Roundup: Market Talk

17 feb 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

17 feb 2026, 21:49 UTC

Acquisities, Fusies, Overnames

Steel Dynamics Says Revised Proposal Continues to Present Highly Strategic Opportunity For SDI Shareholders

17 feb 2026, 21:48 UTC

Acquisities, Fusies, Overnames

Steel Dynamics: BlueScope Offer a 56% Premium to 52-Week Volume Weighted Average Price

17 feb 2026, 21:48 UTC

Acquisities, Fusies, Overnames

Steel Dynamics: Consideration To Be Comprised Entirely of Cash

Peer Vergelijking

Prijswijziging

Evolent Health Inc Prognose

Koersdoel

By TipRanks

186.74% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 8 USD 186.74%

Hoogste 10 USD

Laagste 5 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor Evolent Health Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

7 ratings

Buy

Hold

Sell

Gebaseerd op 7 analisten die aandelenratings hebben gegeven aan Evolent Health Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

10.33 / 10.95Steun & Weerstand

Recent bullish events outweigh bearish events.

All events are bullish.

All events are bearish.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.